Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG - 2Popular Film Areas: A Worldwide Manual for Film Enchantment
- 3Wedding trip Objections in Europe
- 4Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- 5EU chief urges Iran to free imprisoned protesters, lift internet ban
- Exploring the Gig Economy: Examples from Consultants
- The Best Web-based Courses for Ability Advancement
- Sentimental tree to shine at Arctic League annual broadcast
- Don’t let food poisoning crash your Thanksgiving dinner
- Air New Zealand cuts flights and hikes fares as fuel prices surge
- Artemis 2 breaks humanity's all-time distance record during historic loop around the moon (video)
- Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes
- Wegmans recalls mixed nuts over salmonella contamination fears
- Find the Marvels of the World with These Travels
